With our annual MSP Salary Survey closing soon, let’s look at some early results. In positive news, department sizes appear to be increasing with 38.9% of survey respondents reporting that in the past year their department has expanded, compared to 31.1% from our 2022 survey. This year, 14.8% of respondents also reported that their departments had shrunk, down from 18.4% last year.

Once the OPPE/FPPE program is fully designed and implemented, an oversight committee must ensure that the various steps of the process occur as expected and that practitioners adhere to the procedures. An ineffective (but common) approach to program oversight is having the medical staff quality committee, peer review committee, or credentials committee review all OPPE reports. This approach duplicates the work of medical staff leaders, who have already reviewed the reports. It is far more effective for the dedicated clinical staff to manage the review process at the departmental level and to assist the division/section and departmental leaders in ensuring that the OPPE process is carried out accordingly.

According to the American College of Physicians, pulmonary disease is the subspecialty of internal medicine concerned with the diagnosis and management of diseases of the lungs, upper airways, thoracic cavity, and chest wall. Pulmonary disease specialists, or pulmonologists, also have expertise in structural, inflammatory, infectious, and neoplastic disorders of the lung parenchyma, pleura, and airways; pulmonary vascular disease and its effect on the cardiovascular system; and detection and prevention of lung disease due to occupational or environmental causes.